<H1>Chapter DOI: 10.1208/aapsj070480<br/>Cited-By Count: 31</H1><table border="1" width="30%"><tr><td>Total References</td><td>170</td></tr><tr><td>Springer references</td><td>12</td></tr><tr><td>Non Springer references</td><td>158</td></tr><tr><td>BibStructured Count</td><td width="10%">169</td></tr><tr><td>BibUnstructured Count</td><td width="10%">1</td></tr><tr><td>DOI already available in SpringerLink</td><td>136</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>12</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>1</td></tr><tr><td>DOI Obtained For Non Springer</td><td>11</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>12</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibArticle</td><td>Pirmohamed M, Breckenridge A, Kitteringham N, et al. Adverse drug reactions.<Emphasis Type="Italic">BMJ</Emphasis>. 1998;316:1295&#8211;1298.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Vervloet D, Durham S. Adverse reactions to drugs.<Emphasis Type="Italic">BMJ</Emphasis>. 1998;316:1511&#8211;1514.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Naisbitt DJ. Drug hypersensitivity reactions in skin: understanding mechanisms and the development of diagnostic and predictive tests.<Emphasis Type="Italic">Toxicology</Emphasis>. 2004;194:179&#8211;196.</td><td><a href=http://dx.doi.org/10.1016/j.tox.2003.09.004>10.1016/j.tox.2003.09.004</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Svensson CK, Cowen EW, Gaspari AA. Cutaneous drug reactions.<Emphasis Type="Italic">Pharmacol Rev</Emphasis>. 2001;53:357&#8211;379.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Romano A, Torres MJ, Quaratino D, et al. Diagnostic evaluation of delayed hypersensitivity to systematically administered drugs.<Emphasis Type="Italic">Allergy</Emphasis>. 1999;54:23&#8211;27.</td><td><a href=http://dx.doi.org/10.1111/j.1398-9995.1999.tb04431.x>10.1111/j.1398-9995.1999.tb04431.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Saint-Mezard P, Rosieres A, Krasteva M, et al. Allergic contact dermatitis.<Emphasis Type="Italic">Eur J Dermatol.</Emphasis>, 2004;14:284&#8211;295.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1201/b14248-37>10.1201/b14248-37</a></td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Sertoli A, Francalanci S, Acciai MC, et al. Epidemiological survey of contact dermatitis in Italy (1984&#8211;1993) by GIRDCA (Gruppo Italiano Ricerca Dermatiti da Contatto e Ambientali).<Emphasis Type="Italic">Am J Contact Dermat</Emphasis>. 1999,10:18&#8211;30.</td><td><a href=http://dx.doi.org/10.1016/S1046-199X(99)90089-1>10.1016/S1046-199X(99)90089-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Matulich J, Sullivan J. A temporary henna tattoo causing hair and clothing dye allergy.<Emphasis Type="Italic">Contact Dermatitis</Emphasis>. 2005;53:33&#8211;36.</td><td><a href=http://dx.doi.org/10.1111/j.0105-1873.2005.00626.x>10.1111/j.0105-1873.2005.00626.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR9</td><td>BibArticle</td><td>Militello G, James W. Lyral: a fragrance allergen.<Emphasis Type="Italic">Dermatitis</Emphasis>. 2005;16:41&#8211;44.</td><td><a href=http://dx.doi.org/10.1097/01206501-200503000-00009>10.1097/01206501-200503000-00009</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_1, Year, Author_FamilyName_2, VolumeID, JournalTitle, FirstPage, ArticleTitle</td><td>CrossRef</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Bonamonte D, Foti C, Antelmi AR, et al. Nickel contact allergy and menstrual cycle.<Emphasis Type="Italic">Contact Dermatitis</Emphasis>. 2005;52:309&#8211;313.</td><td><a href=http://dx.doi.org/10.1111/j.0105-1873.2005.00588.x>10.1111/j.0105-1873.2005.00588.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Li LY Jr, Cruz PD Jr. Allergic contact dematitis: pathophysiology applied to future therapy.<Emphasis Type="Italic">Dermatol Ther</Emphasis>. 2004;17:219&#8211;223.</td><td><a href=http://dx.doi.org/10.1111/j.1396-0296.2004.04023.x>10.1111/j.1396-0296.2004.04023.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Jensen C, Lisby S, Larsen J, et al. Characterization of lymphocyte subpopulations and cytokine profiles in peripheral blood of nickel-sensitive individuals with systemic contact dermatitis after oral nickel exposure.<Emphasis Type="Italic">Contact Dermatitis</Emphasis>. 2004;50:31&#8211;38.</td><td><a href=http://dx.doi.org/10.1111/j.0105-1873.2004.00294.x>10.1111/j.0105-1873.2004.00294.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Naldi L, Conforti A, Venegoni M, et al. Cutaneous reactions to drugs: an analysis of spontaneous reports in 4 Italian regions.<Emphasis Type="Italic">Br J Clin Pharmacol</Emphasis>. 1999;48:839&#8211;846.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2125.1999.00096.x>10.1046/j.1365-2125.1999.00096.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Shepherd GM. Hypersensitivity reactions to drugs: evaluation and management.<Emphasis Type="Italic">Mt Sinai J Med</Emphasis>. 2003;70:113&#8211;125.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Knowles SR, Shapiro LE, Shear NH. Anticonvulsant hypersensitivity syndrome: incidence, prevention, and management.<Emphasis Type="Italic">Drug Saf</Emphasis>. 1999;21:489&#8211;501.</td><td><a href=http://dx.doi.org/10.2165/00002018-199921060-00005>10.2165/00002018-199921060-00005</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Aronson JK, Ferner RE. Joining the DoTS: new approach to classifying adverse drug reactions.<Emphasis Type="Italic">BMJ</Emphasis>. 2003;327:1222&#8211;1225.</td><td><a href=http://dx.doi.org/10.1136/bmj.327.7425.1222>10.1136/bmj.327.7425.1222</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management.<Emphasis Type="Italic">Lancet</Emphasis>. 2000;356:1255&#8211;1259.</td><td><a href=http://dx.doi.org/10.1016/S0140-6736(00)02799-9>10.1016/S0140-6736(00)02799-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Hari Y, Frutig-Schnyder K, Hurni M, et al. T cell involvement in cutaneous drug eruptions.<Emphasis Type="Italic">Clin Exp Allergy</Emphasis>. 2001;31:1398&#8211;1408.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2222.2001.01164.x>10.1046/j.1365-2222.2001.01164.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Hertl M, Merk HF. Lymphocyte activation in cutaneous drug reactions.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1995;105:95S-98S.</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12316127>10.1111/1523-1747.ep12316127</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Pichler WJ, Schnyder B, Zanni MP, et al. Role of T cells in drug allergies.<Emphasis Type="Italic">Allergy</Emphasis>. 1998;53:225&#8211;232.</td><td><a href=http://dx.doi.org/10.1111/j.1398-9995.1998.tb03881.x>10.1111/j.1398-9995.1998.tb03881.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Bessmertny O, Hatton R, Gonzalez-Peralta R. Antiepileptic hypersensitivity syndrome in children.<Emphasis Type="Italic">Ann Pharmacother</Emphasis>. 2001;35:533&#8211;538.</td><td><a href=http://dx.doi.org/10.1345/aph.10284>10.1345/aph.10284</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Yawalkar N. Drug-induced exanthems.<Emphasis Type="Italic">Toxicology</Emphasis>. 2005;209:131&#8211;134.</td><td><a href=http://dx.doi.org/10.1016/j.tox.2004.12.023>10.1016/j.tox.2004.12.023</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Merk HF. Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines.<Emphasis Type="Italic">Toxicology</Emphasis>. 2005;209:217&#8211;220.</td><td><a href=http://dx.doi.org/10.1016/j.tox.2004.12.026>10.1016/j.tox.2004.12.026</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Britschgi M, Steiner UC, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis.<Emphasis Type="Italic">J Clin Invest</Emphasis>. 2001;107:1433&#8211;1441.</td><td><a href=http://dx.doi.org/10.1172/JCI12118>10.1172/JCI12118</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Miyauchi H, Hosokawa H, Akaeda T, et al. T-cell subsets in drug-induced toxic epidermal necrolysis: possible pathogenic mechanism induced by CD8-positive T cells.<Emphasis Type="Italic">Arch Dermatol</Emphasis>. 1991;127:851&#8211;855.</td><td><a href=http://dx.doi.org/10.1001/archderm.127.6.851>10.1001/archderm.127.6.851</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Pichler WJ. T cells in drug allergy.<Emphasis Type="Italic">Curr Allergy Asthma Rep</Emphasis>. 2002;2:9&#8211;15.</td><td><a href=http://dx.doi.org/10.1007/s11882-002-0032-z>10.1007/s11882-002-0032-z</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Kaplan MH, Hall WW, Susin M, et al. Syndrome of severe skin disease, eiosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection.<Emphasis Type="Italic">Am J Med</Emphasis>. 1991;91:300&#8211;309.</td><td><a href=http://dx.doi.org/10.1016/0002-9343(91)90132-H>10.1016/0002-9343(91)90132-H</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Mauri-Hellweg D, Bettens F, Mauri D, et al. Activation of drug-specific CD4+ and CD8+T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine.<Emphasis Type="Italic">J Immunol</Emphasis>. 1995;155:462&#8211;472.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Schnyder B, Burkhart C, Schnyder-Frutig K, et al. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals.<Emphasis Type="Italic">J Immunol</Emphasis>. 2000;164:6647&#8211;6654.</td><td><a href=http://dx.doi.org/10.4049/jimmunol.164.12.6647>10.4049/jimmunol.164.12.6647</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, ArticleTitle, FirstPage, Author_FamilyName_2, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Zanni MP, von Greyerz S, Schnyder B, et al. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes.<Emphasis Type="Italic">J Clin Invest</Emphasis>. 1998;102:1591&#8211;1598.</td><td><a href=http://dx.doi.org/10.1172/JCI3544>10.1172/JCI3544</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Naisbitt DJ, Farrell J, Wong G, et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity.<Emphasis Type="Italic">J Allergy Clin Immunol</Emphasis>. 2003;111:1393&#8211;1403.</td><td><a href=http://dx.doi.org/10.1067/mai.2003.1507>10.1067/mai.2003.1507</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Nassif A, Bensussan A, Boumsell L, et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.<Emphasis Type="Italic">J Allergy Clin Immunol</Emphasis>. 2004;114:1209&#8211;1215.</td><td><a href=http://dx.doi.org/10.1016/j.jaci.2004.07.047>10.1016/j.jaci.2004.07.047</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Nassif A, Bensussan A, Dorothee G, et al. Drug specific cytotoxic T cells in the skin lesions of a patient with toxic epidermal necrolysis.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 2002;118:728&#8211;733.</td><td><a href=http://dx.doi.org/10.1046/j.1523-1747.2002.01622.x>10.1046/j.1523-1747.2002.01622.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Schnyder B, Frutig K, Mauri-Hellweg D, et al. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazol-induced skin reaction.<Emphasis Type="Italic">Clin Exp Allergy</Emphasis>. 1998;28:1412&#8211;1417.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2222.1998.00419.x>10.1046/j.1365-2222.1998.00419.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Kimbe I, Basketter DA, Gerberick GF, et al. Allergic contact dermatitis.<Emphasis Type="Italic">Int Immunopharmacol</Emphasis>. 2002;2:201&#8211;211.</td><td><a href=http://dx.doi.org/10.1016/S1567-5769(01)00173-4>10.1016/S1567-5769(01)00173-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>De Smedt AC, Van Den Heuvel RL, Van Tendeloo VF, et al. Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitizers and irritants.<Emphasis Type="Italic">Toxicol Lett</Emphasis>. 2005;156:377&#8211;389.</td><td><a href=http://dx.doi.org/10.1016/j.toxlet.2004.12.010>10.1016/j.toxlet.2004.12.010</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity.<Emphasis Type="Italic">Allergy</Emphasis>. 2004;59:809&#8211;820.</td><td><a href=http://dx.doi.org/10.1111/j.1398-9995.2004.00547.x>10.1111/j.1398-9995.2004.00547.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR38</td><td>BibArticle</td><td>Romani N, Holzmann S, Tripp CH, et al. Langerhans cells-dendritic cells of the epidermis.<Emphasis Type="Italic">APMIS</Emphasis>. 2003;111:725&#8211;740.</td><td><a href=http://dx.doi.org/10.1034/j.1600-0463.2003.11107805.x>10.1034/j.1600-0463.2003.11107805.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR39</td><td>BibArticle</td><td>Banerjee G, Damodaran A, Devi N, et al. Role of keratinocytes in antigen presentation and polarization of human T lymphocytes.<Emphasis Type="Italic">Scand J Immunol</Emphasis>. 2004;59:385&#8211;394.</td><td><a href=http://dx.doi.org/10.1111/j.0300-9475.2004.01394.x>10.1111/j.0300-9475.2004.01394.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Park BK, Kitteringham NR, Powell H, et al. Advances in molecular toxicology: towards understanding idiosyncratic drug toxicity.<Emphasis Type="Italic">Toxicology</Emphasis>. 2000;153:39&#8211;60.</td><td><a href=http://dx.doi.org/10.1016/S0300-483X(00)00303-6>10.1016/S0300-483X(00)00303-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Ju C, Uetrecht JP. Detection of 2-hydroxyiminostilbene in the urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1999;288;51&#8211;56.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Madden S, Maggs JL, Park BK. Broactivation of carbamazepine in the rat in vivo: evidence for the formation of reactive arene oxide(s).<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 1996;24:469&#8211;479.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Cribb AE, Miller M, Tesoro A, et al. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 1990;38:744&#8211;751.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Cribb AE, Spielberg SP, Griffin GP. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat hepatic microsomes.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 1995;23:406&#8211;414.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR45</td><td>BibArticle</td><td>Uetrecht JP, Shear, NH, Zahid N. N-chlorination of sulfamethoxazole and dapsone by the myeloperoxidase system.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 1993;21:830&#8211;834.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR46</td><td>BibArticle</td><td>Winter HR, Wang Y, Unadkat JD. CYP2C8/9 mediate dapsone N-hydroxylation at clinical concentrations of dapsone.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 2000:28:865&#8211;868.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR47</td><td>BibArticle</td><td>Mitra AK, Thummel KE, Kalhorn TF, et al. Metabolism of dapsone to its hydroxylamine by CYP2E1 in vitro and in vivo.<Emphasis Type="Italic">Clin Pharmacol Ther</Emphasis>. 1995;58:556&#8211;566.</td><td><a href=http://dx.doi.org/10.1016/0009-9236(95)90176-0>10.1016/0009-9236(95)90176-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR48</td><td>BibArticle</td><td>Reilly TP, Lash LH, Doll MA, et al. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 2000;114:1164&#8211;1173.</td><td><a href=http://dx.doi.org/10.1046/j.1523-1747.2000.00985.x>10.1046/j.1523-1747.2000.00985.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR49</td><td>BibArticle</td><td>Yan Z, Li J, Huebert N, et al. Detection of a novel reactive metabolite of diclofenac: evidence for CYP2C9-mediated bioactivation via arene oxides.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 2005;33:706&#8211;713.</td><td><a href=http://dx.doi.org/10.1124/dmd.104.003095>10.1124/dmd.104.003095</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR50</td><td>BibArticle</td><td>Kumar S, Samuel K, Subramanian R, et al. Extrapolation of diclofenac clearance from in vitro microsomal metabolism data: role of acyl glucuronidation and sequential oxidative metabolism of the acyl glucuronide.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis> 2002; 303:969&#8211;978.</td><td><a href=http://dx.doi.org/10.1124/jpet.102.038992>10.1124/jpet.102.038992</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR51</td><td>BibArticle</td><td>Masubuchi Y, Umeda S, Igarashi S, et al. Participation of the CYP2D subfamily in lidocaine 3-hydroxylation and formation of a reactive metabolite covalently bound to liver microsomal protein in rats.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 1993;46:1867&#8211;1869.</td><td><a href=http://dx.doi.org/10.1016/0006-2952(93)90596-O>10.1016/0006-2952(93)90596-O</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR52</td><td>BibArticle</td><td>Walsh JS, Reese MJ, Thurmond LM. The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes.<Emphasis Type="Italic">Chem Biol Interact</Emphasis>. 2002;142:135&#8211;154.</td><td><a href=http://dx.doi.org/10.1016/S0009-2797(02)00059-5>10.1016/S0009-2797(02)00059-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR53</td><td>BibArticle</td><td>Cuttle L, Munns AJ, Hogg NA,et al. Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation.<Emphasis Type="Italic">Drug Metab Dispos</Emphasis>. 2000;28:945&#8211;950.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR54</td><td>BibArticle</td><td>Uetrecht JP. Reactivity and possible significance of hydroxylamine and nitroso metabolites of procainamide.<Emphasis Type="Italic">J Pharmacol Exp Ther</Emphasis>. 1985;232:420&#8211;425.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR55</td><td>BibArticle</td><td>Swanson HI. Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective.<Emphasis Type="Italic">Chem Biol Interact</Emphasis>. 2004;149:69&#8211;79.</td><td><a href=http://dx.doi.org/10.1016/j.cbi.2004.08.006>10.1016/j.cbi.2004.08.006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR56</td><td>BibArticle</td><td>Janmohamed A, Dolphin CT, Phillips IR, et al. Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 2001;62:777&#8211;786.</td><td><a href=http://dx.doi.org/10.1016/S0006-2952(01)00718-3>10.1016/S0006-2952(01)00718-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR57</td><td>BibArticle</td><td>Lee JL, Mukhtar H, Bickers DR, et al. Cyclooxygenases in the skin: pharmacological and toxicological implications.<Emphasis Type="Italic">Toxicol Appl Pharmacol</Emphasis>. 2003;192:294&#8211;306.</td><td><a href=http://dx.doi.org/10.1016/S0041-008X(03)00301-6>10.1016/S0041-008X(03)00301-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR58</td><td>BibArticle</td><td>Banchereau J, Steinman RM. Dendritic cells and the control of immunity.<Emphasis Type="Italic">Nature</Emphasis>. 1998;392:245&#8211;252.</td><td><a href=http://dx.doi.org/10.1038/32588>10.1038/32588</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR59</td><td>BibArticle</td><td>Randolph GJ. Dendritic cell migration to lymph nodes: cytokines, chemokines, and lipid mediators.<Emphasis Type="Italic">Semin Immunol</Emphasis>. 2001;13:267&#8211;274.</td><td><a href=http://dx.doi.org/10.1006/smim.2001.0322>10.1006/smim.2001.0322</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR60</td><td>BibArticle</td><td>Randolph GJ, Angeli V, Swartz MA. Dendritic-cell trafficking to lymph nodes through lymphatic vessels.<Emphasis Type="Italic">Nat Rev Immunol</Emphasis>. 2005;5:617&#8211;628.</td><td><a href=http://dx.doi.org/10.1038/nri1670>10.1038/nri1670</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR61</td><td>BibArticle</td><td>Kimber I, Cumberbatch M. Dendritic cells and cutaneous immune responses to chemical allergens.<Emphasis Type="Italic">Toxicol Appl Pharmacol</Emphasis>. 1992;117:137&#8211;146.</td><td><a href=http://dx.doi.org/10.1016/0041-008X(92)90230-P>10.1016/0041-008X(92)90230-P</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR62</td><td>BibArticle</td><td>Kimber I, Cumberbatch M, Betts CJ, et al. Dendritic cells and skin sensitization hazard assessment.<Emphasis Type="Italic">Toxicol In Vitro</Emphasis>. 2004;18:195&#8211;202.</td><td><a href=http://dx.doi.org/10.1016/S0887-2333(03)00148-6>10.1016/S0887-2333(03)00148-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR63</td><td>BibArticle</td><td>Shortman K, Liu YJ. Mouse and human dendritic cell subtypes.<Emphasis Type="Italic">Nat Rev Immunol</Emphasis>. 2002;2:151&#8211;161.</td><td><a href=http://dx.doi.org/10.1038/nri746>10.1038/nri746</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR64</td><td>BibArticle</td><td>Becker D, Mohamadzadeh M, Reske K, et al. Increased level of intracellular MHC class II molecules in murine Langerhans cells following in vivo and in vitro administration of contact allergens.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1992;99:545&#8211;549.</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12667308>10.1111/1523-1747.ep12667308</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR65</td><td>BibArticle</td><td>Girolomoni G, Simon JC, Bergstresser PR, et al. Freshly isolated spleen dendritic cells and epidermal Langerhans cells undergo similar phenotypic and functional changes during short-term culture.<Emphasis Type="Italic">J Immunol.</Emphasis> 1990;145:2820&#8211;2826.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR66</td><td>BibArticle</td><td>Neisius U, Brand P, Plochmann S, et al. Detection of increased tyrosine phosphorylation in murine Langerhans cells after stimulation with contact sensitizers.<Emphasis Type="Italic">Arch Dermatol Res</Emphasis>. 1999;291:22&#8211;27.</td><td><a href=http://dx.doi.org/10.1007/s004030050379>10.1007/s004030050379</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR67</td><td>BibArticle</td><td>Aiba S, Katz SI. Phenotypic and functional characteristics of in vivo-activated Langerhans cells.<Emphasis Type="Italic">J Immunol</Emphasis>. 1990;145:2791&#8211;2796.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR68</td><td>BibArticle</td><td>Verrier AC, Schmitt D, Staquet MJ. Fragrance and contact allergens in vitro modulate the HLA-DR and E-cadherin expression on human epidermal Langerhans cells.<Emphasis Type="Italic">Int Arch Allergy Immunol</Emphasis>. 1999;120:56&#8211;62.</td><td><a href=http://dx.doi.org/10.1159/000024220>10.1159/000024220</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR69</td><td>BibArticle</td><td>Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1992;89:1398&#8211;1402.</td><td><a href=http://dx.doi.org/10.1073/pnas.89.4.1398>10.1073/pnas.89.4.1398</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR70</td><td>BibArticle</td><td>Wang B, Feliciani C, Howell BG, et al. Contribution of Langerhans cell-derived IL-18 to contact hypersensitivity.<Emphasis Type="Italic">J Immunol</Emphasis>. 2002;168:3303&#8211;3308.</td><td><a href=http://dx.doi.org/10.4049/jimmunol.168.7.3303>10.4049/jimmunol.168.7.3303</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Author_FamilyName_1, Year, ArticleTitle, FirstPage, VolumeID</td><td>CrossRef</td></tr><tr><td>CR71</td><td>BibArticle</td><td>Kessler BM, Glas R, Ploegh HL. MHC class I antigen processing regulated by cytosolic proteolysis-short cuts that alter peptide generation.<Emphasis Type="Italic">Mol Immunol</Emphasis>. 2002;39:171&#8211;179.</td><td><a href=http://dx.doi.org/10.1016/S0161-5890(02)00100-1>10.1016/S0161-5890(02)00100-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR72</td><td>BibArticle</td><td>Cresswell P. Assembly, transport, and function of MHC class II molecules.<Emphasis Type="Italic">Annu Rev Immunol</Emphasis>. 1994;12:259&#8211;293.</td><td><a href=http://dx.doi.org/10.1146/annurev.iy.12.040194.001355>10.1146/annurev.iy.12.040194.001355</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR73</td><td>BibArticle</td><td>Cresswell P, Androlewicz MJ, Ortmann B. Assembly and transport of class I MHC-peptide complexes.<Emphasis Type="Italic">Ciba Found Symp</Emphasis>. 1994;187:150&#8211;162.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1002/9780470514672.ch10>10.1002/9780470514672.ch10</a></td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Author_FamilyName_1, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR74</td><td>BibArticle</td><td>Park BK, Pirmohamed M, Kitteringham NR. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective.<Emphasis Type="Italic">chem Res Toxicol</Emphasis>. 1998;11:969&#8211;988.</td><td><a href=http://dx.doi.org/10.1021/tx980058f>10.1021/tx980058f</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR75</td><td>BibArticle</td><td>Herouet C, Cottin M, LeClaire J, et al. Contact sensitizers specifically increase MHC class II expression on murine immature dendritic cells.<Emphasis Type="Italic">In Vitr Mol Toxicol</Emphasis>. 2000;13:113&#8211;123.</td><td><a href=http://dx.doi.org/10.1089/109793300440703>10.1089/109793300440703</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR76</td><td>BibArticle</td><td>Cumberbatch M, Dearman RJ, Griffiths CE, et al. Epidermal Langerhans cell migration and sensitization to chemical allergens.<Emphasis Type="Italic">APMIS</Emphasis>. 2003;111:797&#8211;804.</td><td><a href=http://dx.doi.org/10.1034/j.1600-0463.2003.11107811.x>10.1034/j.1600-0463.2003.11107811.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR77</td><td>BibArticle</td><td>Mizuashi M, Ohtani T, Nakagawa S, et al. Redox imbalance induced by contact sensitizers triggers the maturation of dendritic cells.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 2005;124:579&#8211;586.</td><td><a href=http://dx.doi.org/10.1111/j.0022-202X.2005.23624.x>10.1111/j.0022-202X.2005.23624.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR78</td><td>BibArticle</td><td>Chambers CA, Allison JP. Costimulation in T cell responses.<Emphasis Type="Italic">Curr Opin Immunol</Emphasis>. 1997;9:396&#8211;404.</td><td><a href=http://dx.doi.org/10.1016/S0952-7915(97)80087-8>10.1016/S0952-7915(97)80087-8</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR79</td><td>BibArticle</td><td>McAdam AJ, Schweitzer AN, Sharpe AH. The role of B7 costimulation in activation and differentiation of CD4+ and CD8+ T cells.<Emphasis Type="Italic">Immunol Rev</Emphasis>. 1998;165:231&#8211;247.</td><td><a href=http://dx.doi.org/10.1111/j.1600-065X.1998.tb01242.x>10.1111/j.1600-065X.1998.tb01242.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR80</td><td>BibArticle</td><td>Hochweller K, Anderton SM. Kinetics of costimulatory molecule expression by T cells and dendritic cells during the induction of tolerance versus immunity in vivo.<Emphasis Type="Italic">Eur J Immunol</Emphasis>. 2005;35:1086&#8211;1096.</td><td><a href=http://dx.doi.org/10.1002/eji.200425891>10.1002/eji.200425891</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR81</td><td>BibArticle</td><td>Yokozeki H, Takayama K, Ohki O, et al. Comparative analysis of CD8- and CD86 on human Langerhans cells: expression and function.<Emphasis Type="Italic">Arch Dermatol Res</Emphasis>. 1998;290:547&#8211;552.</td><td><a href=http://dx.doi.org/10.1007/s004030050350>10.1007/s004030050350</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR82</td><td>BibArticle</td><td>Wakems P Jr, Burns RP Jr, Ramirez F, et al. Allergens and irritants transcriptionally upregulate CD80 gene expression in human keratinocytes.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 2000;114:1085&#8211;1092.</td><td><a href=http://dx.doi.org/10.1046/j.1523-1747.2000.00997.x>10.1046/j.1523-1747.2000.00997.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR83</td><td>BibArticle</td><td>Fabbri M, Smart C, Pardi R. T lymphocytes.<Emphasis Type="Italic">Int J Biochem Cell Biol</Emphasis>. 2003;35:1004&#8211;1008.</td><td><a href=http://dx.doi.org/10.1016/S1357-2725(03)00037-2>10.1016/S1357-2725(03)00037-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR84</td><td>BibArticle</td><td>Yawalkar N, Hari Y, Frutig K, et al. T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 2000;115:647&#8211;652.</td><td><a href=http://dx.doi.org/10.1046/j.1523-1747.2000.00105.x>10.1046/j.1523-1747.2000.00105.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR85</td><td>BibArticle</td><td>Naisbitt DJ, Britschgi M, Wong G, et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones.<Emphasis Type="Italic">Mol Pharmacol</Emphasis>. 2003;63:732&#8211;741.</td><td><a href=http://dx.doi.org/10.1124/mol.63.3.732>10.1124/mol.63.3.732</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR86</td><td>BibArticle</td><td>Schnyder B, Mauri-Hellweg D, Zanni M, et al. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones.<Emphasis Type="Italic">J Clin Invest</Emphasis>. 1997;100:136&#8211;141.</td><td><a href=http://dx.doi.org/10.1172/JCI119505>10.1172/JCI119505</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR87</td><td>BibArticle</td><td>Zanni MP, Mauri-Hellweg D, Brander C, et al. Characterization of lidocaine-specific T cells.<Emphasis Type="Italic">J Immunol</Emphasis>. 1997;158:1139&#8211;1148.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR88</td><td>BibArticle</td><td>Zanni MP, von Greyerz S, Hari Y, et al. Recognition of local anesthetics by alphabeta+ T cells.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1999;112:197&#8211;204.</td><td><a href=http://dx.doi.org/10.1046/j.1523-1747.1999.00484.x>10.1046/j.1523-1747.1999.00484.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR89</td><td>BibArticle</td><td>Gerber BO, Pichler WJ. Cellular mechanisms of T cell mediated drug hypersensitivity.<Emphasis Type="Italic">Curr Opin Immunol</Emphasis>. 2004;16:732&#8211;737.</td><td><a href=http://dx.doi.org/10.1016/j.coi.2004.09.016>10.1016/j.coi.2004.09.016</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR90</td><td>BibUnstructured</td><td><aug><span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Gerber</span> <span style='background:#DDDDDD'>BO</span></span>, <span style='border:dotted windowtext 1.0pt;padding:0pt'><span style='background:#BCBCBC'>Pichler</span> <span style='background:#DDDDDD'>WJ</span></span></aug>. <span style='background:#FFD9B3'>Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions. <i>AAPS J</i></span>. <span style='background:#FFFF49'>In Press</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR91</td><td>BibArticle</td><td>Santamaria Babi LF, Perez Soler MT, Hauser C, et al. Skin-homing T cells in human cutaneous allergic inflammation.<Emphasis Type="Italic">Immunol Res</Emphasis>. 1995;14:317&#8211;324.</td><td><a href=http://dx.doi.org/10.1007/BF02935627>10.1007/BF02935627</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR92</td><td>BibArticle</td><td>Santamaria LF, Perez Soler MT, Hauser C, et al. Allergen specificity and endothelial transmigration of T cells in allergic contact dermatitis and atopic dermatitis are associated with the cutaneous lymphocyte antigen.<Emphasis Type="Italic">Int Arch Allergy Immunol</Emphasis>. 1995;107:359&#8211;362.</td><td><a href=http://dx.doi.org/10.1159/000237032>10.1159/000237032</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR93</td><td>BibArticle</td><td>Pichler WJ, Yawalkar N, Britschgi M, et al. Cellular and molecular pathophysiology of cutaneous drug reactions.<Emphasis Type="Italic">Am J Clin Dermatol</Emphasis>. 2002;3:229&#8211;238.</td><td><a href=http://dx.doi.org/10.2165/00128071-200203040-00001>10.2165/00128071-200203040-00001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR94</td><td>BibArticle</td><td>Nickoloff BJ, Turka LA. Immunological functions of nonprofessional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytes.<Emphasis Type="Italic">Immunol Today</Emphasis>. 1994;15:464&#8211;469.</td><td><a href=http://dx.doi.org/10.1016/0167-5699(94)90190-2>10.1016/0167-5699(94)90190-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR95</td><td>BibArticle</td><td>Wikner NE, Huff JC, Norris DA, et al. Study of HLA-DR synthesis in cultured human keratinocytes.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1986;87:559&#8211;564.</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12455746>10.1111/1523-1747.ep12455746</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR96</td><td>BibArticle</td><td>Meunier L, Vian L, Lagoueyte C, et al. Quantification of CD1a, HLA-DR, and HLA class I expression on viable human Langerhans cells and keratinocytes.<Emphasis Type="Italic">Cytometry</Emphasis>. 1996;26:260&#8211;264.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1097-0320(19961215)26:4&lt;260::AID-CYTO4&gt;3.0.CO;2-G>10.1002/(SICI)1097-0320(19961215)26:4&lt;260::AID-CYTO4&gt;3.0.CO;2-G</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR97</td><td>BibArticle</td><td>Gueniche A, Viac J, Lizard G, et al. Effect of nickel on the activation state of normal human keratinocytes through interleukin 1 and intercellular adhesion molecule 1 expression.<Emphasis Type="Italic">Br J Dermatol</Emphasis>. 1994;131:250&#8211;256.</td><td><a href=http://dx.doi.org/10.1111/j.1365-2133.1994.tb08500.x>10.1111/j.1365-2133.1994.tb08500.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR98</td><td>BibArticle</td><td>Gueniche A, Viac J, Lizard G, et al. Effect of various metals on intercellular adhesion molecule-1 expression and tumour necrosis factor alpha production by normal human keratinocytes.<Emphasis Type="Italic">Arch Dermatol Res</Emphasis>. 1994;286:466&#8211;470.</td><td><a href=http://dx.doi.org/10.1007/BF00371573>10.1007/BF00371573</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR99</td><td>BibArticle</td><td>Dang LH, Michalek MT, Takei F, et al. Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutants.<Emphasis Type="Italic">J Immunol</Emphasis>. 1990;144:4082&#8211;4091.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR100</td><td>BibArticle</td><td>Piguet PF. Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin.<Emphasis Type="Italic">Springer Semin Immunopathol</Emphasis>. 1992;13:345&#8211;354.</td><td><a href=http://dx.doi.org/10.1007/BF00200533>10.1007/BF00200533</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR101</td><td>BibArticle</td><td>Terunuma A, Aiba S, Tagami H. Cytokine mRNA profiles in cultured human skin component cells exposed to various chemicals: a simulation model of epicutaneous stimuli induced by skin barrier perturbation in comparison with that due to exposure to haptens or irritant.<Emphasis Type="Italic">J Dermatol Sci</Emphasis>. 2001;26:85&#8211;93.</td><td><a href=http://dx.doi.org/10.1016/S0923-1811(00)00165-1>10.1016/S0923-1811(00)00165-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR102</td><td>BibArticle</td><td>Ansel J, Perry P, Brown J, et al. Cytokine modulation of keratinocyte cytokines.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1990;94:101S-107S.</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12876053>10.1111/1523-1747.ep12876053</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR103</td><td>BibArticle</td><td>Sebastiani S, Albanesi C, De PO, et al. The role of chemokines in allergic contact dermatitis.<Emphasis Type="Italic">Arch Dermatol Res</Emphasis>. 2002;293:552&#8211;559.</td><td><a href=http://dx.doi.org/10.1007/s00403-001-0276-9>10.1007/s00403-001-0276-9</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, VolumeID, Author_FamilyName_2, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR104</td><td>BibArticle</td><td>Albanesi C, Scarponi C, Giustizieri ML, et al. Keratinocytes in inflammatory skin diseases.<Emphasis Type="Italic">Curr Drug Targets Inflamm Allergy</Emphasis>. 2005;4:329&#8211;334.</td><td><a href=http://dx.doi.org/10.2174/1568010054022033>10.2174/1568010054022033</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR105</td><td>BibArticle</td><td>Cumberbatch M, Bhushan M, Dearman RJ, et al. IL-1beta-induced Langerhans&#8217; cell migration and TNF-alpha production in human skin: regulation by lactoferrin.<Emphasis Type="Italic">Clin Exp Immunol</Emphasis>. 2003;132:352&#8211;359.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2249.2003.02146.x>10.1046/j.1365-2249.2003.02146.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR106</td><td>BibArticle</td><td>Cumberbatch M, Dearman RJ, Griffiths CE, et al. Langerhans cell migration.<Emphasis Type="Italic">Clin Exp Dermatol</Emphasis>. 2000;25:413&#8211;418.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2230.2000.00678.x>10.1046/j.1365-2230.2000.00678.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR107</td><td>BibArticle</td><td>Cumberbatch M, Griffiths CE, Tucker SC, et al. Tumour necrosis factor-alpha induces Langerhans cell migration in humans.<Emphasis Type="Italic">Br J Dermatol</Emphasis>. 1999;141:192&#8211;200.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2133.1999.02964.x>10.1046/j.1365-2133.1999.02964.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR108</td><td>BibArticle</td><td>Nassif A., Moslehi H, Le Gouvello S, et al. Evaluation of the potential role of cytokines in toxic epidernal necrolysis.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 2004;123:850&#8211;855.</td><td><a href=http://dx.doi.org/10.1111/j.0022-202X.2004.23439.x>10.1111/j.0022-202X.2004.23439.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR109</td><td>BibArticle</td><td>Hulette BA, Ryan CA, Gerberick GF. Elucidating changes in surface marker expression of dendritic cells following chemical allergen treatment.<Emphasis Type="Italic">Toxicol Appl Pharmacol</Emphasis>. 2002;182:226&#8211;233.</td><td><a href=http://dx.doi.org/10.1006/taap.2002.9447>10.1006/taap.2002.9447</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR110</td><td>BibArticle</td><td>Albanesi C, Cavani A, Girolomoni G. Interferon-gamma-stimulated human keratinocytes express the genes necessary for the production of peptide-loaded MHC class II molecules.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1998;110:138&#8211;142.</td><td><a href=http://dx.doi.org/10.1046/j.1523-1747.1998.00098.x>10.1046/j.1523-1747.1998.00098.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR111</td><td>BibArticle</td><td>Basham TY, Nickoloff BJ, Merigan TC, et al. Recombinatn gamma interferon induces HLA-DR expression on cultured human keratinocytes.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1984;83:88&#8211;90.</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12262597>10.1111/1523-1747.ep12262597</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR112</td><td>BibArticle</td><td>Lisby S, Muller KM, Jongeneel CV, et al. Nickel and skin irritants up-regulate tumor necrosis factor-alpha mRNA in keratinocytes by different but potentially synergistic mechanisms.<Emphasis Type="Italic">Int Immunol</Emphasis>. 1995;7:343&#8211;352.</td><td><a href=http://dx.doi.org/10.1093/intimm/7.3.343>10.1093/intimm/7.3.343</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR113</td><td>BibArticle</td><td>Wilmer JL, Burleson FG, Kayama F, et al. Cytokine induction in human epidermal keratinocytes exposed to contact irritants and its relation to chemical-induced inflammation in mouse skin.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1994;102:915&#8211;922.</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12383512>10.1111/1523-1747.ep12383512</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR114</td><td>BibArticle</td><td>Piguet PF, Grau GE, Hauser C, et al. Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions.<Emphasis Type="Italic">J Exp Med</Emphasis>. 1991;173:673&#8211;679.</td><td><a href=http://dx.doi.org/10.1084/jem.173.3.673>10.1084/jem.173.3.673</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR115</td><td>BibArticle</td><td>Vandebriel RJ, Van Och FM, van Loveren H. In vitro assessment of sensitizing activity of low molecular weight compounds.<Emphasis Type="Italic">Toxicol Appl Pharmacol</Emphasis>. 2005;207:142&#8211;148.</td><td><a href=http://dx.doi.org/10.1016/j.taap.2005.01.054>10.1016/j.taap.2005.01.054</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR116</td><td>BibArticle</td><td>O&#8217;Garra A, McEvoy LM, Zlotnik A. T-cell subsets: chemokine receptors guide the way.<Emphasis Type="Italic">Curr Biol</Emphasis>. 1998;8:R646-R649.</td><td><a href=http://dx.doi.org/10.1016/S0960-9822(07)00413-7>10.1016/S0960-9822(07)00413-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR117</td><td>BibArticle</td><td>Lebrec H, Kerdine S, Gaspard I, et al. Th(1)/Th(2) responses to drugs.<Emphasis Type="Italic">Toxicology</Emphasis>. 2001;158:25&#8211;29.</td><td><a href=http://dx.doi.org/10.1016/S0300-483X(00)00398-X>10.1016/S0300-483X(00)00398-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR118</td><td>BibArticle</td><td>Umetsu DT, DeKruyff RH. Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases.<Emphasis Type="Italic">Proc Soc Exp Biol Med</Emphasis>. 1997;215:11&#8211;20.</td><td><a href=http://dx.doi.org/10.3181/00379727-215-44109>10.3181/00379727-215-44109</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Author_FamilyName_1, Year, VolumeID, ArticleTitle, FirstPage</td><td>CrossRef</td></tr><tr><td>CR119</td><td>BibArticle</td><td>Xu H, DiIulio NA, Fairchild RL. T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukins (II) 4/II-10-producing (Th2) negative regulatory CD4+T cells.<Emphasis Type="Italic">J Exp Med</Emphasis>. 1996;183:1001&#8211;1012.</td><td><a href=http://dx.doi.org/10.1084/jem.183.3.1001>10.1084/jem.183.3.1001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR120</td><td>BibArticle</td><td>Fuchs J, Zollner TM, Kaufmann R, et al. Redox-modulated pathways in inflammatory skin diseases.<Emphasis Type="Italic">Free Radic Biol Med</Emphasis>. 2001;30:337&#8211;353.</td><td><a href=http://dx.doi.org/10.1016/S0891-5849(00)00482-2>10.1016/S0891-5849(00)00482-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR121</td><td>BibArticle</td><td>Steinbrink K, Sorg C, Macher E. Low zone tolerance to contact allergens in mice: a functional role for CD8+T helper type 2 cells.<Emphasis Type="Italic">J Exp Med</Emphasis>. 1996;183:759&#8211;768.</td><td><a href=http://dx.doi.org/10.1084/jem.183.3.759>10.1084/jem.183.3.759</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR122</td><td>BibArticle</td><td>Dearman RJ, Basketter DA, Kimber I. Characterization of chemical allergens as a function of divergent cytokine secretion profiles induced in mice.<Emphasis Type="Italic">Toxicol Appl Pharmacol</Emphasis>. 1996;138:308&#8211;316.</td><td><a href=http://dx.doi.org/10.1006/taap.1996.0129>10.1006/taap.1996.0129</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR123</td><td>BibArticle</td><td>Dieli F, Asherson GL, Sireci G, et al. Development of IFN-gammaproducing CD8+ gamma delta+T lymphocytes and IL-2-producing CD4+ alpha beta+T lymphocytes during contact sensitivity.<Emphasis Type="Italic">J Immunol</Emphasis>. 1997;158:2567&#8211;2575.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR124</td><td>BibArticle</td><td>Blaise GA, Gauvin D, Gangal M, et al. Intric oxide, cell signaling and cell death.<Emphasis Type="Italic">Toxicology</Emphasis>. 2005;208:177&#8211;192.</td><td><a href=http://dx.doi.org/10.1016/j.tox.2004.11.032>10.1016/j.tox.2004.11.032</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR125</td><td>BibArticle</td><td>Ross R, Reske-Kunz AB. The role of NO in contact hypersensitivity.<Emphasis Type="Italic">Int Immunopharmacol</Emphasis>. 2001;1:1469&#8211;1478.</td><td><a href=http://dx.doi.org/10.1016/S1567-5769(01)00091-1>10.1016/S1567-5769(01)00091-1</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR126</td><td>BibArticle</td><td>Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V. Nitric oxide in human skin: current status and future prospects.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1998;110:1&#8211;7.</td><td><a href=http://dx.doi.org/10.1046/j.1523-1747.1998.00084.x>10.1046/j.1523-1747.1998.00084.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR127</td><td>BibArticle</td><td>Weller R. Nitric oxide: a key mediator in cutaneous physiology.<Emphasis Type="Italic">Clin Exp Dermatol</Emphasis>. 2003;28:511&#8211;514.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2230.2003.01365.x>10.1046/j.1365-2230.2003.01365.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR128</td><td>BibArticle</td><td>Deliconstantinos G, Villiotou V, Stravrides JC. Release by ultraviolet B (u.v.B) radiation of nitric oxide (NO) from human keratinocytes: a potential role for nitric oxide in erythema production.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1995;114:1257&#8211;1265.</td><td><a href=http://dx.doi.org/10.1111/j.1476-5381.1995.tb13341.x>10.1111/j.1476-5381.1995.tb13341.x</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, VolumeID, Author_FamilyName_2, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR129</td><td>BibArticle</td><td>Nathan C. Inducible nitric oxide synthase: what difference does it make?.<Emphasis Type="Italic">J Clin Invest</Emphasis>. 1997;100:2417&#8211;2423.</td><td><a href=http://dx.doi.org/10.1172/JCI119782>10.1172/JCI119782</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR130</td><td>BibArticle</td><td>Arany I, Brysk MM, Brysk H, et al. Induction of iNOS mRNA by interferon-gamma in epithelial cells is associated with growth arrest and differentiation.<Emphasis Type="Italic">Cancer Lett</Emphasis>. 1996;110:93&#8211;96.</td><td><a href=http://dx.doi.org/10.1016/S0304-3835(96)04476-X>10.1016/S0304-3835(96)04476-X</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR131</td><td>BibArticle</td><td>Qureshi AA, Hosoi J, Xu S, et al. Langerhans cells express inducible nitric oxide synthase and produce nitric oxide.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1996;107:815&#8211;821.</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12330572>10.1111/1523-1747.ep12330572</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR132</td><td>BibArticle</td><td>Rocha IM, Guillo LA. Lipopolysaccharide and cytokines induce nitric oxide synthase and produce nitric oxide in cultured normal human melanocytes.<Emphasis Type="Italic">Arch Dermatol Res</Emphasis>. 2001;293:245&#8211;248.</td><td><a href=http://dx.doi.org/10.1007/s004030100211>10.1007/s004030100211</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR133</td><td>BibArticle</td><td>Chang HR, Tsao DA, Wang SR, et al. Expression of nitric oxide synthases in keratinocytes after UVB irradiation.<Emphasis Type="Italic">Arch Dermatol Res</Emphasis>. 2003;295:293&#8211;296.</td><td><a href=http://dx.doi.org/10.1007/s00403-003-0433-4>10.1007/s00403-003-0433-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR134</td><td>BibArticle</td><td>Warren JB. Nitric oxide and human skin blood flow responses to acetylcholine and ultraviolet light.<Emphasis Type="Italic">FASEB J</Emphasis>. 1994;8:247&#8211;251.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR135</td><td>BibArticle</td><td>Lerner LH, Qureshi AA, Reddy BV, et al. Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 2000;114:196&#8211;199.</td><td><a href=http://dx.doi.org/10.1046/j.1523-1747.2000.00816.x>10.1046/j.1523-1747.2000.00816.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR136</td><td>BibArticle</td><td>Rowe A, Farrell AM, Bunker CB. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses.<Emphasis Type="Italic">Br J Dermatol</Emphasis>. 1997;136:18&#8211;23.</td><td><a href=http://dx.doi.org/10.1046/j.1365-2133.1997.d01-1136.x>10.1046/j.1365-2133.1997.d01-1136.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR137</td><td>BibArticle</td><td>Lippe IT, Stabentheiner A, Holzer P. Participation of nitric oxide in the mustard oil-induced neurogenic inflammation of the rat paw skin.<Emphasis Type="Italic">Eur J Pharmacol</Emphasis>. 1993;232:113&#8211;120.</td><td><a href=http://dx.doi.org/10.1016/0014-2999(93)90735-Z>10.1016/0014-2999(93)90735-Z</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR138</td><td>BibArticle</td><td>Morita H, Hori M, Kitano Y. Modulation of picryl chloride-induced contact hypersensitivity reaction in mice by nitric oxide.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1996;107:549&#8211;552.</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12582805>10.1111/1523-1747.ep12582805</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR139</td><td>BibArticle</td><td>Ross R, Gillitzer C, Kleinz R, et al. Involvement of NO in contact hypersensitivity.<Emphasis Type="Italic">Int Immunol</Emphasis>. 1998;10:61&#8211;69.</td><td><a href=http://dx.doi.org/10.1093/intimm/10.1.61>10.1093/intimm/10.1.61</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR140</td><td>BibArticle</td><td>Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls.<Emphasis Type="Italic">Cell</Emphasis>. 1994;78:915&#8211;918.</td><td><a href=http://dx.doi.org/10.1016/0092-8674(94)90266-6>10.1016/0092-8674(94)90266-6</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR141</td><td>BibArticle</td><td>Forstermann U, Closs EI, Pollock JS, et al. Nitric oxide synthase isozymes: characterization, purification, molecular cloning, and functions.<Emphasis Type="Italic">Hypertension</Emphasis>. 1994;23:1121&#8211;1131.</td><td><a href=http://dx.doi.org/10.1161/01.HYP.23.6.1121>10.1161/01.HYP.23.6.1121</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>VolumeID, JournalTitle, FirstPage, Author_FamilyName_1, Year, Author_FamilyName_2</td><td>CrossRef</td></tr><tr><td>CR142</td><td>BibArticle</td><td>Wanikiat P, Woodward DF, Armstrong RA. Investigation of the role of nitric oxide and cyclic GMP in both the activation and inhibition of human neutrophils.<Emphasis Type="Italic">Br J Pharmacol</Emphasis>. 1997;122:1135&#8211;1145.</td><td><a href=http://dx.doi.org/10.1038/sj.bjp.0701477>10.1038/sj.bjp.0701477</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR143</td><td>BibArticle</td><td>Shin WS, Hong YH, Peng HB, et al. Nitric oxide attenuates vascular smooth muscle cell activation by interferon-gamma: the role of constitutive NF-kappa B activity.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1996;271:11317&#8211;11324.</td><td><a href=http://dx.doi.org/10.1074/jbc.271.10.5647>10.1074/jbc.271.10.5647</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR144</td><td>BibArticle</td><td>Bonham CA, Lu L, Li Y, et al. Nitric oxide production by mouse bone marrow-derived dendritic cells: implications for the regulation of allogeneic T cell responses.<Emphasis Type="Italic">Transplantation</Emphasis>. 1996;62:1871&#8211;1877.</td><td><a href=http://dx.doi.org/10.1097/00007890-199612270-00033>10.1097/00007890-199612270-00033</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR145</td><td>BibArticle</td><td>Lu L, Bonham CA, Chambers FG, et al. Induction of nitric oxide synthase in mouse dendritic cells by IFN-gamma, endotoxin, and interaction with allogeneic T cells: nitric oxide production is associated with dendritic cell apoptosis.<Emphasis Type="Italic">J Immunol</Emphasis>. 1996;157:3577&#8211;3586.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR146</td><td>BibArticle</td><td>Virag L, Szabo E, Bakondi E, et al. Nitric oxide-peroxynitritepoly(ADP-ribose) polymerase pathway in the skin.<Emphasis Type="Italic">Exp Dermatol</Emphasis>. 2002;11:189&#8211;202.</td><td><a href=http://dx.doi.org/10.1034/j.1600-0625.2002.110301.x>10.1034/j.1600-0625.2002.110301.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR147</td><td>BibArticle</td><td>Briganti S, Picardo M. Antioxidant activity, lipid peroxidation and skin diseases: what&#8217;s new.<Emphasis Type="Italic">J Eur Acad Dermatol Venereol</Emphasis>. 2003;17:663&#8211;669.</td><td><a href=http://dx.doi.org/10.1046/j.1468-3083.2003.00751.x>10.1046/j.1468-3083.2003.00751.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR148</td><td>BibArticle</td><td>Chain BM. Current issues in antigen presentation: focus on the dendritic cell.<Emphasis Type="Italic">Immunol Lett</Emphasis>. 2003;89:237&#8211;241.</td><td><a href=http://dx.doi.org/10.1016/S0165-2478(03)00151-2>10.1016/S0165-2478(03)00151-2</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR149</td><td>BibArticle</td><td>Hubbard AK, Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades.<Emphasis Type="Italic">Free Radic Biol Med</Emphasis>. 2000;28:1379&#8211;1386.</td><td><a href=http://dx.doi.org/10.1016/S0891-5849(00)00223-9>10.1016/S0891-5849(00)00223-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR150</td><td>BibArticle</td><td>Rutault K, Alderman C, Chain BM, et al. Reactive oxygen species activate human peripheral blood dendritic cells.<Emphasis Type="Italic">Free Radic Biol Med</Emphasis>. 1999;26:232&#8211;238.</td><td><a href=http://dx.doi.org/10.1016/S0891-5849(98)00194-4>10.1016/S0891-5849(98)00194-4</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR151</td><td>BibArticle</td><td>Verhasselt V, Goldman M, Willems F. Oxidative stress up-regulates IL-8 and TNF-alpha synthesis by human dendritic cells.<Emphasis Type="Italic">Eur J Immunol</Emphasis>. 1998;28:3886&#8211;3890.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1521-4141(199811)28:11&lt;3886::AID-IMMU3886&gt;3.0.CO;2-M>10.1002/(SICI)1521-4141(199811)28:11&lt;3886::AID-IMMU3886&gt;3.0.CO;2-M</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR152</td><td>BibArticle</td><td>Mates JM, Perez-Gomez C, Olalla L, et al. Allergy to drugs: antioxidant enzymic activities, lipid peroxidation and protein oxidative damage in human blood.<Emphasis Type="Italic">Cell Biochem Funct</Emphasis>. 2000;18:77&#8211;84.</td><td><a href=http://dx.doi.org/10.1002/(SICI)1099-0844(200006)18:2&lt;77::AID-CBF851&gt;3.0.CO;2-Z>10.1002/(SICI)1099-0844(200006)18:2&lt;77::AID-CBF851&gt;3.0.CO;2-Z</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR153</td><td>BibArticle</td><td>Coopman SA, Johnson RA, Platt R, et al. Cutaneous disease and drug reactions in HIV infection.<Emphasis Type="Italic">N Engl J Med</Emphasis>. 1993;328:1670&#8211;1674.</td><td><a href=http://dx.doi.org/10.1056/NEJM199306103282304>10.1056/NEJM199306103282304</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR154</td><td>BibArticle</td><td>Buhl R, Jaffe HA, Holroyd KJ, et al. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals.<Emphasis Type="Italic">Lancet</Emphasis>. 1989;2:1294&#8211;1298.</td><td><a href=http://dx.doi.org/10.1016/S0140-6736(89)91909-0>10.1016/S0140-6736(89)91909-0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR155</td><td>BibArticle</td><td>Kaur S, Zilmer M, Eisen M, et al. Patients with allergic and irritant contact dermatitis are characterized by striking change of iron and oxidized glutathione status in nonlesional area of the skin.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 2001;116:886&#8211;890.</td><td><a href=http://dx.doi.org/10.1046/j.0022-202x.2001.01374.x>10.1046/j.0022-202x.2001.01374.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR156</td><td>BibArticle</td><td>Kaur S, Zilmer M, Eisen M, et al. Nickel sulphate and epoxy resin: differences in iron status and glutathione redox ration at the time of patch testing.<Emphasis Type="Italic">Arch Dermatol Res</Emphasis>. 2004;295:517&#8211;520.</td><td><a href=http://dx.doi.org/10.1007/s00403-004-0462-7>10.1007/s00403-004-0462-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR157</td><td>BibArticle</td><td>Nordberg J, Zhong L, Holmgren A, et al. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue.<Emphasis Type="Italic">J Biol Chem</Emphasis>. 1998;273:10835&#8211;10842.</td><td><a href=http://dx.doi.org/10.1074/jbc.273.18.10835>10.1074/jbc.273.18.10835</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR158</td><td>BibArticle</td><td>Vyas PM, Roychowdhury S, Woster PM, et al. Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhy droxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes.<Emphasis Type="Italic">Biochem Pharmacol</Emphasis>. 2005;70:275&#8211;286.</td><td><a href=http://dx.doi.org/10.1016/j.bcp.2005.04.023>10.1016/j.bcp.2005.04.023</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR159</td><td>BibArticle</td><td>Kantengwa S, Jornot L, Devenoges C, et al. Superoxide anions induce the maturation of human dendritic cells.<Emphasis Type="Italic">Am J Respir Crit Care Med</Emphasis>. 2003;167:431&#8211;437.</td><td><a href=http://dx.doi.org/10.1164/rccm.200205-425OC>10.1164/rccm.200205-425OC</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR160</td><td>BibArticle</td><td>Chen KH, Reece LM, Leary JF. Mitochondrial glutathione modulates TNF-alpha-induced endothelial cell dysfunction.<Emphasis Type="Italic">Free Radic Biol Med</Emphasis>. 1999;27:100&#8211;109.</td><td><a href=http://dx.doi.org/10.1016/S0891-5849(99)00059-3>10.1016/S0891-5849(99)00059-3</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR161</td><td>BibArticle</td><td>Ikeda M, Schroeder KK, Mosher LB, et al. Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes.<Emphasis Type="Italic">J Invest Dermatol</Emphasis>. 1994;103:791&#8211;796.</td><td><a href=http://dx.doi.org/10.1111/1523-1747.ep12413176>10.1111/1523-1747.ep12413176</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR162</td><td>BibArticle</td><td>Faruqi RM, Poptic EJ, Faruqi TR, et al. Distinct mechanisms for N-acetylcysteine inhibition of cytokine-induced E-selectin and VCAM-1 expression.<Emphasis Type="Italic">Am J Physiol</Emphasis>. 1997;273:H817-H826.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR163</td><td>BibArticle</td><td>Matsue H, Edelbaum D, Shalhevet D, et al. Generation and function of reactive oxygen species in dendritic cells during antigen presentation.<Emphasis Type="Italic">J Immunol</Emphasis>. 2003;171:3010&#8211;3018.</td><td><a href=http://dx.doi.org/10.4049/jimmunol.171.6.3010>10.4049/jimmunol.171.6.3010</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, FirstPage, VolumeID, Author_FamilyName_2, Year, Author_FamilyName_1</td><td>CrossRef</td></tr><tr><td>CR164</td><td>BibArticle</td><td>Sandstrom PA, Buttke TM. Autocrine production of extracellular catalase prevents apoptosis of the human CEM T-cell line in serum-free medium.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1993;90:4708&#8211;4712.</td><td><a href=http://dx.doi.org/10.1073/pnas.90.10.4708>10.1073/pnas.90.10.4708</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR165</td><td>BibArticle</td><td>Kannan K, Jain SK. Oxidative stress and apoptosis.<Emphasis Type="Italic">Pathophysiology</Emphasis>. 2000;7:153&#8211;163.</td><td><a href=http://dx.doi.org/10.1016/S0928-4680(00)00053-5>10.1016/S0928-4680(00)00053-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR166</td><td>BibArticle</td><td>Ogawa Y, Kobayashi T, Nishioka A, et al. Reactive oxygen species-producing site in hydrogen peroxide-induced apoptosis of human peripheral T cells: involvement of lysosomal membrane destabilization.<Emphasis Type="Italic">Int J Mol Med</Emphasis>. 2004;13:383&#8211;388.</td><td><a href=http://dx.doi.org/10.3892/ijmm.13.3.383>10.3892/ijmm.13.3.383</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>ArticleTitle, Author_FamilyName_2, Author_FamilyName_1, Year</td><td>CrossRef</td></tr><tr><td>CR167</td><td>BibArticle</td><td>Devadas S, Zaritskaya L, Rhee SG, et al. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression.<Emphasis Type="Italic">J Exp Med</Emphasis>. 2002;195:59&#8211;70.</td><td><a href=http://dx.doi.org/10.1084/jem.20010659>10.1084/jem.20010659</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR168</td><td>BibArticle</td><td>Hildeman DA, Zhu Y, Mitchell TC, et al. Activated T cell death in vivo mediated by proapoptotic bcl-2 family membber bim.<Emphasis Type="Italic">Immunity</Emphasis>. 2002;16:759&#8211;767.</td><td><a href=http://dx.doi.org/10.1016/S1074-7613(02)00322-9>10.1016/S1074-7613(02)00322-9</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR169</td><td>BibArticle</td><td>Fuchs J, Packer L. Antioxidant protection from solar-simulated radiation-induced suppression of contact hypersensitivity to the recall antigen nickel sulfate in human skin.<Emphasis Type="Italic">Free Radic Biol Med</Emphasis>. 1999;27:422&#8211;427.</td><td><a href=http://dx.doi.org/10.1016/S0891-5849(99)00081-7>10.1016/S0891-5849(99)00081-7</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR170</td><td>BibArticle</td><td>Pasche-Koo F, Arechalde A, Arrighi JF, et al. Effect of N-acetylcysteine, an inhibitor of tumor necrosis factor, on irritant contact dermatitis in the human.<Emphasis Type="Italic">Curr Probl Dermatol</Emphasis>. 1995;23:198&#8211;206.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1159/000424316>10.1159/000424316</a></td><td><b>CrossRef-Meta</b></td>
<td>FirstPage, Author_FamilyName_2, Author_FamilyName_1</td><td>CrossRef</td></tr></table>